Female Athlete Triad and RED-S: Energy Availability Research

A 2014 prospective cohort study by Tenforde et al. found that female collegiate cross-country runners with menstrual irregularity had 2.7 times the bone stress injury rate of eumenorrheic teammates — translating to a season-ending diagnosis every 3.8 years versus every 10.2 years for regularly menstruating athletes. This single statistic encapsulates why Relative Energy Deficiency in Sport (RED-S) is the most consequential under-addressed health issue in female athletic performance. What was originally described as the Female Athlete Triad (low energy availability, menstrual dysfunction, low bone mineral density) is now understood as a systemic metabolic syndrome affecting immunological function, cardiovascular health, psychological well-being, and measurable power output — not just the three original components.

This review synthesizes research from 2000 to 2024 on the mechanisms, prevalence, performance consequences, screening tools, and refeeding protocols for RED-S in competitive female athletes.

From the Triad to RED-S: Conceptual Evolution

The Female Athlete Triad was first formally defined by the American College of Sports Medicine in 1997, describing a clinical syndrome of disordered eating, amenorrhea, and osteoporosis. The model was critically important in raising awareness but had two limitations: it implied a strict causal sequence (disordered eating → menstrual dysfunction → bone loss), and it excluded male athletes who exhibit the same metabolic cascade under energy restriction.

In 2014, the IOC Consensus Statement introduced Relative Energy Deficiency in Sport (RED-S) to expand the framework. RED-S defines low energy availability (LEA) as the root cause and recognizes its effects across 10 physiological systems: metabolic rate, menstrual function, bone health, immunity, protein synthesis, cardiovascular function, psychological health, growth and development, hematological parameters, and glycogen metabolism.

Critically, RED-S applies to male athletes as well, though this review focuses on female-specific evidence where the literature is most developed. Prevalence estimates for LEA in female athletes range from 22% in recreational populations to 58% in elite aesthetic and endurance sports (Sundgot-Borgen & Torstveit, 2004).

The Energy Availability Threshold

Energy availability (EA) is defined as dietary energy intake minus exercise energy expenditure, normalized to fat-free mass: EA = (dietary intake kcal − exercise expenditure kcal) / fat-free mass kg. This is distinct from energy balance, which compares total intake to total expenditure and does not account for the metabolic demands of supporting physiological processes.

Landmark research by Loucks et al. (2003) established that hypothalamic suppression of LH pulsatility — the hormonal trigger for menstrual irregularity — begins at EA below approximately 30 kcal/kg FFM/day. Optimal physiological function requires EA of 45+ kcal/kg FFM/day. Between these thresholds lies a zone of subclinical functional impairment where athletes feel and perform normally in the short term but are accumulating bone density deficits and hormonal disruption without clinical symptoms.

For a 60-kg athlete with 45 kg of fat-free mass, the critical 30 kcal/kg FFM threshold equals approximately 1,350 kcal/day available for physiological function after exercise costs — a level easily crossed on training days with moderate energy intake and high training load.

Bone Health Consequences

Bone health consequences of RED-S are mediated through two complementary pathways: hormonal suppression of bone formation and nutritional deficit in bone-forming substrates.

Low estrogen from hypothalamic amenorrhea reduces osteoblast activity and increases RANKL-driven osteoclast recruitment, accelerating bone resorption. In contrast to postmenopausal bone loss where baseline bone density has been accumulated, RED-S affects athletes during the peak bone accrual years (16–25 years old) — meaning the deficit may be permanent rather than recoverable with subsequent treatment.

Simultaneously, low EA often correlates with inadequate calcium and vitamin D intake. Athletes with EA below 30 kcal/kg FFM/day average calcium intake of 700–850 mg/day in most survey studies (Nattiv et al., 2007), well below the 1,500 mg/day recommended for female athletes with menstrual dysfunction.

The outcome is measurable bone mineral density (BMD) reduction: female athletes with functional hypothalamic amenorrhea for 12+ months show trabecular BMD Z-scores of −1.5 to −2.0 at the lumbar spine — values typically associated with women 15–20 years older. Stress fracture incidence rises sharply below BMD Z-scores of −1.0 at weight-bearing sites.

Menstrual Dysfunction and Hormonal Cascade

Menstrual dysfunction in RED-S exists on a spectrum: eumenorrhea (normal cycles of 21–35 days) → oligomenorrhea (cycles 35–90 days or fewer than 9 cycles per year) → amenorrhea (no period for 90+ days). Functional hypothalamic amenorrhea (FHA) — the form seen in RED-S — is distinguished from primary ovarian insufficiency by its reversibility with energy restoration.

The hormonal cascade begins with kisspeptin neuron suppression in the arcuate nucleus of the hypothalamus. Kisspeptin is the primary activator of GnRH pulsatility; when metabolic signals indicate energy deficit, kisspeptin activity is inhibited, reducing GnRH pulse frequency, blunting LH and FSH secretion, and ultimately failing to drive follicular development and ovulation. This is a adaptive energy conservation response — reproduction is metabolically expensive and deprioritized when substrate availability is insufficient.

Secondary hormonal effects include: elevated cortisol (reflecting metabolic stress), reduced IGF-1, suppressed T3 (thyroid hormone), and decreased leptin — all of which impair muscle protein synthesis and skeletal adaptation to training independently of the estrogen deficit.

Measurable Performance Impairment

RED-S produces quantifiable performance decrements that extend well beyond the expected consequences of weight loss. A landmark study by Heikura et al. (2018) tracking elite female distance runners found that athletes classified as LEA had 8.3% lower 5km performance times and 12% lower peak velocity at VO2max compared to energy-sufficient controls, despite similar total training loads.

The mechanisms for performance impairment are multi-system:

• Reduced glycogen synthesis: LEA impairs hepatic and muscle glycogen storage efficiency. Athletes in LEA have approximately 20–30% lower resting muscle glycogen concentrations at equivalent carbohydrate intakes compared to energy-sufficient athletes (Mountjoy et al., 2018).
• Impaired muscle protein synthesis: Suppressed IGF-1 and elevated cortisol shift the muscle protein balance negative, impairing training adaptation even when dietary protein intake appears adequate.
• Reduced neuromuscular function: Countermovement jump height and rate of force development are measurably reduced in athletes with clinically confirmed LEA, reflecting impaired neural drive and reduced phosphocreatine availability.
• Psychological effects: Irritability, impaired concentration, and depressed mood (common in RED-S) reduce training quality and competitive focus independently of physical performance capacity.

Screening, Detection, and Risk Stratification

The IOC RED-S Clinical Assessment Tool (RED-S CAT, Mountjoy et al., 2015) provides a structured framework for risk stratification. Athletes are classified as low, moderate, or high risk based on combinations of menstrual history, bone mineral density, eating behavior, and clinical indicators. High-risk athletes (those with eating disorders, BMD Z-scores below −2.0, or two or more prior stress fractures) are recommended to be removed from training until medical clearance is obtained.

Practical screening markers for coaches without clinical access:

• Menstrual tracking: three or more missed or delayed cycles in any 12-month period warrants medical referral.
• Training load to performance ratio: worsening performance despite maintained training load, particularly declining jump height over 3+ consecutive weeks, is a RED-S warning sign.
• Unexplained fatigue: persistent RPE elevation at standard training intensities without illness or overtraining explanation.
• Recurrent soft tissue and stress fractures: two bone stress injuries within a 12-month period in a female athlete under 30 requires mandatory RED-S screening.

Return-to-Performance Energy Refeeding

Recovery from RED-S requires sustained energy availability restoration, not short-term nutritional supplementation. Research by De Souza et al. (2019) demonstrated that restoring menstrual function — the clinical benchmark for hormonal recovery — required EA above 45 kcal/kg FFM/day for a minimum of 3–6 months. The timeline for bone density recovery is substantially longer: BMD improvements of 2–5% per year are typical after hormonal recovery, but the deficit accumulated over 2–3 years of LEA may require 5–8 years of optimal energy availability to fully resolve at trabecular bone sites.

Key nutrition targets during recovery:

• Minimum EA of 45 kcal/kg FFM/day (non-negotiable target, not an average).
• Calcium intake 1,500 mg/day (from food where possible, supplemented if necessary).
• Vitamin D 2,000–4,000 IU/day to achieve serum 25(OH)D above 40 ng/mL.
• Protein 1.8–2.0 g/kg body weight to support muscle protein synthesis recovery.

Performance monitoring during refeeding using objective markers such as CMJ height and MCV trends provides a non-invasive indicator of neuromuscular recovery before hormonal and bone parameters normalize. Typically, power and velocity metrics recover within 4–8 weeks of EA restoration, preceding the 3–6 month timeline for menstrual recovery — providing an earlier confirmation that refeeding is producing its intended physiological effect.